Joseph Carver of the Perelman School of Medicine comments on doctors’ increased focus on the long-term effects of cancer treatment.
Perelman School of Medicine
Next Generation Gene Therapy: Penn Study Shows Potential of Gene Vector to Broaden Eye-Disease Treatment
Philadelphia — Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blinding disorders.
Philadelphia — There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. In the largest genetics study of the disease, three new genes associated with risk for PSP were identified and two additional genetic variants affecting risk for PSP were confirmed.
Jeffrey Weiser and post-doctoral research Thomas Clarke of the Perelman School of Medicine are cited for their research on microbes.
Michael Cirigliano of the Perelman School of Medicine comments on digesting too much vitamin A.
Joseph Sobanko of the Perelman School of Medicine discusses why higher SPFs are not more effective than others.
PHILADELPHIA – A team of social scientists and medical and nursing researchers in the United States and the United Kingdom has pinpointed how a program, which ran in more than 100 hospital intensive care units in Michigan, dramatically reduced the rates of potentially deadly central line bloodstream infections to become one of the world’s most successful patient-safety programs.
PHILADELPHIA -- A University of Pennsylvania study will determine if public transit can convey more than people going from point A to point B. Video displays on public buses in Los Angeles will be used to help determine the efficacy of an innovative soap opera-like video program designed to increase HIV testing among low-income African Americans 14 to 24 years of age.